Ophthalmology CFO

Your ASC is your most valuable asset. Do you know what it is actually worth?

Strategic financial guidance for ophthalmologist-owners managing multi-entity practices, equipment decisions, and growth opportunities.

Take the 4-Minute Financial Assessment →

A 4-minute test your accountant hopes you skip.

Ophthalmology Practices

At a glance

InvestmentStarting at $4,000/mo
ContractMonth-to-month after onboarding
IncludesTwo CFO calls a month + full financial package
Add-onsASC valuation, PE analysis, equipment ROI modeling
Guarantee45-day money back

TL;DR — What is a Ophthalmology Fractional CFO?

A fractional CFO for ophthalmology practices provides strategic financial leadership for eye care groups — covering ASC joint venture structures, LASIK vs. medical revenue strategy, and practice valuation for PE or DSO partnerships — typically engaged by ophthalmologist-owners generating $3M–$20M who are making major capital or exit decisions. Sorso is a fractional CFO firm that does this for ophthalmology practices across the US, from $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee.

Industry Context

The Strategic Picture for Ophthalmology Practices

Ophthalmology is one of the most attractive specialties for private equity consolidation. Retina-focused platforms (Retina Consultants of America), general ophthalmology platforms (EyeCare Partners, US Eye, Unifeye Vision Partners, Chicago Pacific Founders), and vision-integrated platforms continue aggressive roll-up activity. FOCUS Investment Banking's April 2026 benchmarks put ophthalmology add-on deals at 6 to 10 times EBITDA and platform deals at 10 to 15 times, and credit ASC ownership with 1 to 3 extra turns. A practice with a partially-owned ASC, strong cataract volume, and retina or oculoplastic subspecialty coverage gets a higher multiple.

The CFO conversations in ophthalmology are unusually capital-intensive. Equipment decisions (femtosecond lasers, phacoemulsification systems, OCT imaging, visual field equipment) are large and lumpy, and each needs a case-volume forecast behind it. Premium IOL programs require pricing strategy, patient financing, and clinical staff training. ASC expansion or acquisition decisions involve regulatory considerations (Certificate of Need in some states), capital structure, and partner economics. These are large capital decisions that need real modeling, not intuition.

Is This Right for You?

This service is for ophthalmology practice owners facing these challenges:

You co-own an ASC and need to evaluate whether to expand capacity, bring in new surgeons, or sell your share
LASIK volume is declining nationally and you need to decide how much to invest in marketing vs pivoting to premium IOLs
A PE-backed ophthalmology group wants to acquire your practice and you need someone to analyze the deal structure beyond the headline number
Your optometrists generate patient flow but you are not sure their compensation is aligned with profitability
Equipment technology changes every few years and you need a capital planning strategy, not one-off purchase decisions

Need accurate books first? Our Accounting service for ophthalmology practices may be a better starting point.

Strategic Pitfalls

CFO-Level Mistakes We See in Ophthalmology Practices

The strategic and capital-allocation errors that cost ophthalmology practice owners the most.

01

Underinvesting in premium IOL penetration

Premium lenses made up about 21 percent of U.S. cataract surgeries in 2025, according to Market Scope data in RxSight's 2025 annual report. Each conversion adds a patient-paid fee that the same filing puts at $2,000 to $5,000 per eye. Counselor training and patient education drive this number more than physician preference.

02

Buying a femtosecond laser without volume modeling

A femtosecond laser is a large capital purchase that also carries a per-case cost for procedure licenses and disposables. An equipment market report cited in LENSAR's 2025 annual report put the industry average at 496 procedures a year per installed laser. Without a realistic volume projection and premium IOL attach rate assumption, the laser can lose money for years. Real ROI analysis is required before purchase.

03

Not monetizing ASC ownership properly

Ophthalmologists often own ASC investor shares but do not track ASC distributions separately from clinical income. When planning an exit, the ASC interest often has significant independent value that owners have not quantified.

04

Accepting the first PE offer without subspecialty analysis

A retina practice attached to a general ophthalmology group may be individually worth more to a retina-focused consolidator than to the general platform bidder. Without knowing which buyers pay most for which subspecialty, owners can leave real money on the table.

05

Under-pricing optical shop services

Optical dispensers and retail pricing is often set based on cost-plus rather than market value. A well-priced optical can earn a high gross margin (in the Management & Business Academy's Key Metrics data, the top 30 percent of independent optometry practices made 66 to 75 percent on eyewear, against a 61 percent median), while one priced below market earns little and adds almost nothing to practice EBITDA.

The Numbers That Matter

CFO Dashboard Metrics for Ophthalmology Practices

Adjusted EBITDA

Earnings before interest, taxes, depreciation, and amortization with owner compensation normalized.

Combined EBITDA Margin

Adjusted EBITDA across practice and ASC as a percentage of combined collections.

ASC EBITDA Margin

What we look for: At or above the 29.5 percent operating margin of Pennsylvania ASCs in 2024 (MedPAC)

ASC net income plus depreciation and amortization, divided by ASC collections.

Premium IOL Revenue

Non-covered premium lens revenue collected directly from patients.

Equipment ROI Period

What we look for: Under 36 months for major capital

Months to recoup equipment capital cost through incremental case revenue.

Subspecialty Mix

Revenue by subspecialty (general, cornea, retina, glaucoma, oculoplastic) as percentage of total.

Days Cash on Hand

What we look for: 60 to 120 days

Cash reserves divided by average daily operating expenses.

Capital & Vendor Strategy

Equipment, Software, and Partner Decisions

Capital allocation in ophthalmology is particularly complex because decisions span the practice, the optical shop, and the ASC. Each requires different ROI modeling. A femtosecond laser affects practice and ASC economics simultaneously; an optical inventory investment affects only the optical shop; an ASC expansion involves regulatory, capital, and partner considerations.

From an M&A perspective, the subspecialty mix matters enormously. Retina practices trade at premiums because of anti-VEGF drug spread and predictable injection volume. Cataract-heavy general practices with ASC participation trade at premiums because of ASC economics. Glaucoma and medical eye practices trade at lower multiples because of lower margin profile. A CFO guides the owner through understanding which parts of their practice are most valuable to which buyers, and how to position for the most favorable transaction.

What's Included

How a Fractional CFO Works for Ophthalmology Practices

Ophthalmology-specific strategic leadership that goes beyond reporting.

01

ASC Strategy & Valuation

  • •ASC ownership share valuation
  • •Capacity expansion vs partner surgeon recruitment analysis
  • •ASC syndication and management company evaluation
02

Capital & Equipment Planning

  • •Multi-year equipment replacement and upgrade roadmap
  • •Femtosecond laser ROI analysis
  • •Diagnostic technology investment prioritization
  • •Financing structure optimization
03

Growth Strategy

  • •Premium service line development (premium IOLs, dry eye, cosmetic)
  • •Satellite location vs referral network strategy
  • •Optometrist partnership models
04

M&A and Exit Planning

  • •Practice valuation with ophthalmology-specific multiples
  • •PE platform and add-on analysis
  • •Succession planning and partner transitions

Results

Results in this example

MetricIn this example
ASC reallocationCorrecting shared-cost allocation added several hundred thousand dollars to reported practice profit
Premium IOL marginMargin roughly doubled through pricing and implant cost negotiation, adding six figures annually
Optical shop improvementMargin moved into the high 20s through vendor consolidation, adding roughly $90K annually

Illustrative Scenario

What This Looks Like In Practice

Illustrative, not a client testimonial. Illustrative composite, not a real client and not an endorsement of Sorso by any named client. Numbers are shown as representative ranges.

A multi-surgeon ophthalmology practice with ASC ownership, an optical shop, and employed optometrists, combined revenue in the $8M–$10M range. Owner-surgeon take-home was below expectations. Nobody could clearly explain the financial relationship between the practice, the ASC, and the optical shop.

What the review found:

  • •ASC cost allocation subsidizing practice overhead by several hundred thousand dollars a year, so the practice looked profitable only because the ASC was absorbing shared costs disproportionately
  • •Premium IOL upgrades generating meaningful patient revenue but at a sub-25% margin, driven by untracked implant costs and under-priced upgrade fees
  • •The optical shop running at a low-double-digit margin, with frame purchasing fragmented across multiple vendors
  • •Anti-VEGF drug waste billing (JW modifier) not being submitted, leaving mid-five figures in unbilled drug waste per year

Representative results

Correcting shared-cost allocation added several hundred thousand dollars to reported practice profit

ASC reallocation

Margin roughly doubled through pricing and implant cost negotiation, adding six figures annually

Premium IOL margin

Margin moved into the high 20s through vendor consolidation, adding roughly $90K annually

Optical shop improvement

The takeaway

The lesson from this example: without clean separation between practice, ASC, and optical, shared costs quietly migrate to whichever entity the GL defaults to. One entity ends up looking healthy while another absorbs the difference.

Think your ophthalmology practice has similar potential?

Common Questions About Fractional CFO for Ophthalmology Practices

How much does a fractional CFO for ophthalmology practices cost?+

Fractional CFO starts at $4,000 a month, month-to-month after onboarding, with a 45-day money-back guarantee. It usually pays off from about $3M in revenue; below that, accounting from $2,000 a month is the better first step, and we will say so.

Do you also keep the books?+

If you want us to. Sorso's accounting service runs the monthly close, with separate P&Ls for the practice, the ASC and optical, and the CFO work sits on top of it. If you already have a bookkeeper or controller, we work from their books. We are not a CPA firm, so tax filing stays with your CPA.

Do you work with ophthalmology practices in my state?+

Yes. We work with ophthalmology practices across the US. The work runs on your accounting, billing and payroll systems, so where the practice is does not change it.

How do you value an ophthalmology practice with ASC ownership?+

Separately. The practice and ASC have different multiples and different buyer pools. We value each entity, model the combined economics, and help you understand what a buyer is actually paying for.

Should we invest in a femtosecond laser?+

We model the ROI based on your cataract volume, premium IOL conversion rate, and the price you can charge for laser-assisted surgery. The payback period varies enormously based on volume — we calculate yours specifically.

How do you approach PE deals in ophthalmology?+

We analyze the full structure: practice valuation, ASC valuation, retained equity terms, management fees, employment agreements, and earnout provisions. The headline number is often misleading in eye care deals.

Should we bring more surgeons into the ASC?+

We model the impact: additional case volume, shared cost reduction, scheduling constraints, and ownership dilution. More surgeons mean more revenue but also more complexity — the math is specific to your situation.

How do we grow premium service revenue?+

We start with your current premium IOL conversion rate, dry eye treatment revenue, and cosmetic offerings. Then we model the financial impact of improving conversion, adding services, and marketing investment. Small conversion rate improvements drive large revenue changes in ophthalmology.

What is the biggest financial oversight in ophthalmology?+

Ignoring optical shop economics. The optical shop is often treated as a convenience, not a profit center. With good vendor management and pricing it can earn a solid margin, and it needs its own P&L so you can see whether it does.

Stop guessing. Start leading your ophthalmology practice with data.

Take the 4-minute financial assessment—and find out if your ophthalmology practice is ready for strategic CFO leadership.

Curious what you'd actually receive each month? See a sample monthly report →

By state

Ophthalmology Practices accounting and CFO support, by state

State-level tax, payer, and regulatory context shapes what “good” looks like for ophthalmology practices practices. The pages below walk through each state's specifics.